Factors associated with abnormal spirometry among HIV-infected individuals
- PMID: 26372280
- PMCID: PMC4571285
- DOI: 10.1097/QAD.0000000000000750
Factors associated with abnormal spirometry among HIV-infected individuals
Abstract
Objective: HIV-infected individuals are susceptible to development of chronic lung diseases, but little is known regarding the prevalence and risk factors associated with different spirometric abnormalities in this population. We sought to determine the prevalence, risk factors and performance characteristics of risk factors for spirometric abnormalities among HIV-infected individuals.
Design: Cross-sectional cohort study.
Methods: We analyzed cross-sectional US data from the NHLBI-funded Lung-HIV consortium - a multicenter observational study of heterogeneous groups of HIV-infected participants in diverse geographic sites. Logistic regression analysis was performed to determine factors statistically significantly associated with spirometry patterns.
Results: A total of 908 HIV-infected individuals were included. The median age of the cohort was 50 years, 78% were men and 68% current smokers. An abnormal spirometry pattern was present in 37% of the cohort: 27% had obstructed and 10% had restricted spirometry patterns. Overall, age, smoking status and intensity, history of Pneumocystis infection, asthma diagnosis and presence of respiratory symptoms were independently associated with an abnormal spirometry pattern. Regardless of the presence of respiratory symptoms, five HIV-infected participants would need to be screened with spirometry to diagnose two individuals with any abnormal spirometry pattern.
Conclusions: Nearly 40% of a diverse US cohort of HIV-infected individuals had an abnormal spirometry pattern. Specific characteristics including age, smoking status, respiratory infection history and respiratory symptoms can identify those at risk for abnormal spirometry. The high prevalence of abnormal spirometry and the poor predictive capability of respiratory symptoms to identify abnormal spirometry should prompt clinicians to consider screening spirometry in HIV-infected populations.
Conflict of interest statement
All authors report no relevant conflicts of interest related to this manuscript.
Figures
Similar articles
-
Adolescent age is an independent risk factor for abnormal spirometry among people living with HIV in Kenya.AIDS. 2018 Jun 19;32(10):1353-1359. doi: 10.1097/QAD.0000000000001815. AIDS. 2018. PMID: 29794491 Free PMC article.
-
Chronic lung disease in HIV-infected children established on antiretroviral therapy.AIDS. 2016 Nov 28;30(18):2795-2803. doi: 10.1097/QAD.0000000000001249. AIDS. 2016. PMID: 27662546 Free PMC article.
-
Lung function in men with and without HIV.AIDS. 2020 Jul 1;34(8):1227-1235. doi: 10.1097/QAD.0000000000002526. AIDS. 2020. PMID: 32287070 Free PMC article.
-
HIV-associated obstructive lung diseases: insights and implications for the clinician.Lancet Respir Med. 2014 Jul;2(7):583-92. doi: 10.1016/S2213-2600(14)70017-7. Epub 2014 May 13. Lancet Respir Med. 2014. PMID: 24831854 Free PMC article. Review.
-
Bronchiectasis and other chronic lung diseases in adolescents living with HIV.Curr Opin Infect Dis. 2017 Feb;30(1):21-30. doi: 10.1097/QCO.0000000000000325. Curr Opin Infect Dis. 2017. PMID: 27753690 Free PMC article. Review.
Cited by
-
Pulmonary function tests and their associated factors in people living with HIV at Jimma medical center; Ethiopia: a comparative cross-sectional study.Front Reprod Health. 2023 Oct 13;5:1178304. doi: 10.3389/frph.2023.1178304. eCollection 2023. Front Reprod Health. 2023. PMID: 37901155 Free PMC article.
-
Association Between CD4+, Viral Load, and Pulmonary Function in HIV.Lung. 2017 Oct;195(5):635-642. doi: 10.1007/s00408-017-0030-5. Epub 2017 Jun 24. Lung. 2017. PMID: 28647827
-
A Novel CD4+ T Cell-Dependent Murine Model of Pneumocystis-driven Asthma-like Pathology.Am J Respir Crit Care Med. 2016 Oct 1;194(7):807-820. doi: 10.1164/rccm.201511-2205OC. Am J Respir Crit Care Med. 2016. PMID: 27007260 Free PMC article.
-
Implementation of a COPD Screening Questionnaire in an Outpatient HIV Clinic.COPD. 2016 Dec;13(6):767-772. doi: 10.3109/15412555.2016.1161016. Epub 2016 Apr 20. COPD. 2016. PMID: 27096708 Free PMC article.
-
Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996-2015: a retrospective population-based cohort study.CMAJ Open. 2020 Feb 18;8(1):E83-E89. doi: 10.9778/cmajo.20190028. Print 2020 Jan-Mar. CMAJ Open. 2020. PMID: 32071142 Free PMC article.
References
-
- Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11–19. - PubMed
-
- Braithwaite RS, Justice AC, Chang CC, Fusco JS, Raffanti SR, Wong JB, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med. 2005;118:890–898. - PubMed
-
- Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BD, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA. 2008;300:550–554. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 AI031834/AI/NIAID NIH HHS/United States
- UO1-AI-35042/AI/NIAID NIH HHS/United States
- R01 HL090342/HL/NHLBI NIH HHS/United States
- K23 HL103192/HL/NHLBI NIH HHS/United States
- UO1-AI-35040/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- UM1 AI035043/AI/NIAID NIH HHS/United States
- R01HL090313/HL/NHLBI NIH HHS/United States
- R01 HL090313/HL/NHLBI NIH HHS/United States
- K24 AI118591/AI/NIAID NIH HHS/United States
- R01 HL090335/HL/NHLBI NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- U01 HL121814/HL/NHLBI NIH HHS/United States
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01 DA036297/DA/NIDA NIH HHS/United States
- UO1-HD-32632/HD/NICHD NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- U01 AI037984/AI/NIAID NIH HHS/United States
- UL1TR000124/TR/NCATS NIH HHS/United States
- UO1-AI-34994/AI/NIAID NIH HHS/United States
- R01 HL090483/HL/NHLBI NIH HHS/United States
- UO1-AI-34989/AI/NIAID NIH HHS/United States
- UL1 RR024153/RR/NCRR NIH HHS/United States
- UO1-AI-37984/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- R01 HL090316/HL/NHLBI NIH HHS/United States
- U01 AI037613/AI/NIAID NIH HHS/United States
- UO1-AI-35041/AI/NIAID NIH HHS/United States
- M01 RR000722/RR/NCRR NIH HHS/United States
- UO1-AI-35004/AI/NIAID NIH HHS/United States
- R01 HL090331/HL/NHLBI NIH HHS/United States
- UO1-AI-34993/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- R01HL090483/HL/NHLBI NIH HHS/United States
- K24 HL087713/HL/NHLBI NIH HHS/United States
- UL1 TR000424/TR/NCATS NIH HHS/United States
- R01 HL090339/HL/NHLBI NIH HHS/United States
- UO1-AI-35039/AI/NIAID NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- R01HL090331/HL/NHLBI NIH HHS/United States
- UO1-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- 5-MO1-RR-00722/RR/NCRR NIH HHS/United States
- UO1-AI-31834/AI/NIAID NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 AI103408/AI/NIAID NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- UO1-AI-35043/AI/NIAID NIH HHS/United States
- R01 HL126549/HL/NHLBI NIH HHS/United States
- UO1-AI-37613/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States